- Home
- / Hexamer Therapeutics
Hexamer Therapeutics
Hexamer Therapeutics Summary
Company Summary
- Overview
- Hexamer Therapeutics is a company developing COVID-19 vaccines and platforms. It also addresses the idea of developing a vaccine against heterogeneous metastatic cancer tumors.
- Type
- Private
- Status
- Active
- Founded
- 2019
- HQ
- Pullman, WA, US | view all locations
Table of Contents
Key People
Keith Miller, Chief Technology Officer
Colin Collins, Chief Scientific Officer
Operating MetricsView all
Projects
4
May, 2023